This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Asian Pacific Association for the Study of the Liver | |
|---|---|
| Name | Asian Pacific Association for the Study of the Liver |
| Abbreviation | APASL |
| Formation | 1978 |
| Type | Professional association |
| Region served | Asia Pacific |
| Headquarters | Tokyo |
| Membership | Hepatology professionals |
Asian Pacific Association for the Study of the Liver is a regional professional association dedicated to the study, research, prevention, and management of liver diseases across the Asia Pacific region. The association convenes clinicians, researchers, and public health officials from countries including Japan, China, India, Australia, South Korea, Singapore, Thailand, and Philippines to address viral hepatitis, hepatocellular carcinoma, and nonalcoholic fatty liver disease through conferences, guidelines, and collaborative research. APASL engages with international bodies and national societies to harmonize clinical practice and advance training among specialists drawn from institutions such as The University of Tokyo, Peking University, All India Institute of Medical Sciences, and Monash University.
APASL was founded in the late 1970s following meetings among hepatologists from Japan, Taiwan, Hong Kong, Malaysia, Indonesia, and Pakistan who had participated in events hosted by World Health Organization, International Coalition of Hepatology Societies, and regional congresses in Bangkok and Seoul. Early leaders included physicians affiliated with Osaka University, National Taiwan University, Queen Mary Hospital (Hong Kong), and Christian Medical College, Vellore who collaborated with researchers from Centers for Disease Control and Prevention and the National Institutes of Health to map viral hepatitis epidemiology. The association established periodic scientific meetings patterned after the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases, while fostering ties with universities such as Kyoto University, Fudan University, Korea University, and University of Malaya.
APASL's core objectives include standardizing diagnosis and treatment protocols across nations including Vietnam, Bangladesh, Sri Lanka, and Nepal and promoting research into pathogens like Hepatitis B virus, Hepatitis C virus, and emerging agents studied at facilities such as Pasteur Institute and Walter Reed Army Institute of Research. The association issues clinical practice guidance comparable to documents from World Health Organization, European Centre for Disease Prevention and Control, and Centers for Disease Control and Prevention while supporting registry initiatives like those at Seoul National University Hospital and Prince of Wales Hospital (Hong Kong). APASL also advocates for equitable access to antiviral agents developed by companies such as Gilead Sciences, Roche, and AbbVie and for vaccination programs modeled on campaigns led by Bill & Melinda Gates Foundation and UNICEF.
APASL is governed by an elected council and executive committee with representation from national societies including Japanese Society of Gastroenterology, Chinese Medical Association, Indian Association for the Study of the Liver, Australian Gastroenterological Association, and Korean Association for the Study of the Liver. Membership categories encompass clinicians from Mayo Clinic, Cleveland Clinic, and regional centers like Sir Ganga Ram Hospital, Prince of Songkla Hospital, and Siriraj Hospital, as well as scientists from institutions such as Karolinska Institute, Oxford University, and Harvard Medical School. The governance model follows nonprofit frameworks used by organizations like World Medical Association and International Council of Ophthalmology with bylaws and ethics oversight influenced by standards from Declaration of Helsinki and Council for International Organizations of Medical Sciences.
APASL organizes the annual APASL Conference and specialized meetings similar in scope to the European Association for the Study of the Liver Congress, AASLD Liver Meeting, and International Liver Congress. Meetings have been hosted in cities including Tokyo, Shanghai, New Delhi, Sydney, Seoul, and Kuala Lumpur and feature presentations from investigators associated with Imperial College London, University College London, Johns Hopkins University, Yale University, and University of California, San Francisco. APASL publishes clinical practice guidelines, consensus statements, and proceedings that are cited alongside journals such as Hepatology, Journal of Hepatology, The Lancet, The New England Journal of Medicine, BMJ, and specialty outlets like Liver International and Journal of Viral Hepatitis.
APASL runs research fellowships, multicenter trials, and training workshops drawing participants from University of Hong Kong, King's College London, University of Toronto, McGill University, and National University of Singapore. Research priorities parallel initiatives at Wellcome Trust, National Cancer Institute, and European Research Council and include cohort studies, randomized controlled trials, and translational work with laboratories at Cold Spring Harbor Laboratory, Salk Institute, and Riken. Educational programs include hands-on hepatology courses, liver transplant symposia referencing practices at Cleveland Clinic and Mayo Clinic, and online modules akin to offerings from Coursera and edX hosted in partnership with academic centers such as Stanford University and Duke University.
APASL collaborates with international organizations including World Health Organization, United Nations, Gavi, and specialist societies like European Association for the Study of the Liver, American Association for the Study of Liver Diseases, African Association for the Study of Liver, and national bodies such as Taiwan Association for the Study of Liver Diseases and Philippine Society of Gastroenterology. Partnerships extend to research consortia at Bill & Melinda Gates Foundation, pharmaceutical companies like GlaxoSmithKline and Merck & Co., and academic networks including Global Health Network and Asia Pacific Consortium on Hepatitis B. Collaborative outputs inform policy at ministries of health in Indonesia, Malaysia, Brunei, Laos, and Cambodia and align with regional public health strategies advanced at forums like Asia-Pacific Economic Cooperation and ASEAN.
Category:Medical associations Category:Hepatology